The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.
Claudia Oshry is candid about restarting GLP-1 medications after welcoming son Reuben, calling it a 'relief' that helped her stay present during pregnancy and breastfeeding. The Toast host loves low-lift wellness like water, electrolytes, sun, and Dulcolax gummies for gut health. Now embracing her postpartum body, she blocks GLP-1 criticism amid life-changing results.
Ozempic has transformed weight loss by silencing 'food noise' for many users, but now 'Ozempic personality' is sparking debate. A report highlights mental health complaints during treatment. Is this side effect real, or just hype?
Authorities in India have seized more than 260 suspected fake Mounjaro pens, uncovering a counterfeit operation sourcing peptides from Alibaba and selling them cheaply on IndiaMART. The primary accused lacked a pharmaceutical license and produced them at a private property. This incident underscores growing risks in the booming obesity drug market as Mounjaro becomes India's top-seller.
Musician Adele transformed her body in 2020, losing 100 pounds via exercise and a healthy diet amid rising anxiety after her 2019 divorce. Before Ozempic and Mounjaro gained popularity, she focused on building physical and mental strength. Her before-and-after photos and candid interviews reveal a powerful story of self-improvement.
The launch of generic Semaglutide in India has rapidly captured 33% market share within just 10 days, according to CLSA's channel checks, primarily benefiting Torrent Pharmaceuticals, Dr. Reddy's Laboratories, and Zydus Lifesciences. This surge has dented Eli Lilly's Mounjaro share from 61% to 56%. As generics make GLP-1 therapies more accessible, what does this mean for patients with type 2 diabetes and obesity?
In India, the GLP-1 rush is on—patients demand Ozempic or Mounjaro by name, generics slash costs to ₹1,290/month, fueled by Instagram and forums. But endocrinologists caution against indiscriminate use amid nausea, rebound weight, and serious risks. Inside the hype reshaping obesity treatment.
Popular drugs like semaglutide and tirzepatide are transforming weight loss for type 2 diabetes and obesity patients. But a new UNC study warns of hidden muscle loss that could impact strength and mobility. Here's what the research means for safe, healthy weight management.
Health Canada recently warned Canadians not to buy or use unauthorized injectable peptide drugs amid reports of adverse reactions. Yet CBC News effortlessly purchased three such products online from different sellers. Experts highlight serious risks and contrast them with regulated GLP-1 medications like Ozempic and Wegovy.
